Janus Henderson Group PLC Pardes Biosciences, Inc. Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.84 - $8.57 $1.29 Million - $3.9 Million
-454,895 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$5.64 - $15.64 $652,350 - $1.81 Million
-115,665 Reduced 20.27%
454,895 $3.29 Million
Q4 2021

Feb 14, 2022
BUY
$9.8 - $17.02 $5.59 Million - $9.71 Million
570,560 New
570,560 $9.29 Million

Others Institutions Holding PRDS

# of Institutions
2
Shares Held
5.23M
Call Options Held
0
Put Options Held
0
View Full List

About PARDES BIOSCIENCES, INC.

PRDS Quotes by TradingView
  • Ticker PRDS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,320,900
  • Description
  • Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...
More about PRDS
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email